title: Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use.
authors.affiliation: Service d'Anesthesie-Reanimation Chirurgicale, Université Paris Descartes, Hopital Cochin, Paris, France. yves.ozier@cch.aphp.fr
authors.forename: Y
authors.initials: Y
authors.lastname: Ozier
authors.forename: B J
authors.initials: BJ
authors.lastname: Hunt
mesh_terms: D000818:Animals; D016913:Blood Component Transfusion; D005169:Factor VIII / Q000627:therapeutic use; D005340:Fibrinogen / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000097:blood / Q000517:prevention & control*; D006487:Hemostasis / Q000187:drug effects*; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D006490:Hemostatics; C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen